CED Life Science Conference 2013 Agenda
The life science industry is changing. At the CED Life Science Conference 2013, we address the challenges that companies will face in 2013 and beyond, with a particular eye towards the interaction of startups, pharmaceutical companies and healthcare providers and the impact of the Affordable Care Act.
Join more than 1,000 of your peers and participate in partnering meetings throughout the CED Life Science Conference 2013. These sessions will provide you valuable opportunities to discuss potential licensing deals with investors, corporate groups, and tech transfer officers The CED Life Science Conference 2013 also showcases the innovation occurring at biopharma and medtech startups, with an understanding of the change, challenges and opportunities within the industry. Registration is now closed - but you may register on-site at the CED Life Science Conference on February 27 & 28, 2013.
AGENDA
Wednesday, February 27, 20139:00 am - 5:00 pm | Partnering Meetings | 10:00 am - 12:45 pm | Entrepreneur Workshop: How to Build a Successful Life Science Company (Free)
(Free for Life Science Entrepreneurs Only, Pre-registration Required at this webpage) "Selling the Sizzle" - Tim Willis, President, CEO & Co-Founder, TearScience® "Clinical Strategies" - Jeff Williams, CEO, Clinipace Worldwide "Attracting Capital - Expectations and Valuations" - Robert Schotzinger, M.D., Ph.D., President, CEO & Director, Viamet Pharmaceuticals "Working With Your Board and Advisory Panel" - Richard O. Brajer, President & CEO, LipoScience, Inc. "Attracting Top Talent" - Mark A. Sirgo, Pharm.D., President & CEO, BioDelivery Sciences International (BDSI) "Pitching to Strategic Partners" - Kenneth Moch, President & CEO, Chimerix
| 11:30 am - 12:45 pm | Joint Board Lunch - CED, NC Biotechnology Center, NCBIO (Invitation Only) | 11:30 am - 2:00 pm | Venture Day, hosted by LabCorp® (for venture capital investors, by invitation only) | 12:00 pm - 6:00 pm | Conference Registration Open | 1:00 pm - 2:30 pm
| Opening Remarks & Keynote Speaker
Joan Siefert Rose, President, CED E. Norris Tolson, President & CEO, North Carolina Biotechnology Center J. Bradley Wilson, President & CEO, Blue Cross and Blue Shield of North Carolina Samuel Nussbaum, M.D., EVP, Clinical Health Policy & Chief Medical Officer, WellPoint, Inc.
Annual Life Science Industry Report, presented by Deloitte LLP Jacques Mulder, Principal, Chief Strategy Officer, Deloitte Life Sciences and Health Care Practice
| 2:30 pm - 2:50 pm | Networking Break | 2:50 pm - 3:40 pm | Life Science Leadership Panel David P. King, Chairman & CEO, LabCorp® (Moderator) Roger L. (Vern) Davenport, CEO, M*Modal Stephen A. Hill, M.D., President & CEO, Targacept Anne Whitaker, President, North America Pharmaceuticals, Sanofi
| 3:40 pm - 4:00 pm | Networking Break | 4:00 pm - 4:45 pm | New Business Models in BioPharma Brian S. Williams, Director, Global Healthcare Strategy, PwC (Moderator) Lynn Marks, M.D., SVP, PCPS, GlaxoSmithKline; Corporate Secretary and Chair of Operations Committee for TransCelerate Biopharma William F. Greenlee, Ph.D., President & CEO, The Hamner Institutes for Health Sciences Seth Rudnick, M.D., Venture Partner, Canaan Partners Melissa Stevens, Deputy Executive Director, FasterCures
| 4:00 pm - 4:45 pm | New Business Models in Medtech Cindy Clark, President, ibiliti (Moderator) Justin Klein, M.D., Partner, NEA Fred McCoy, President & CEO, NeuroTronik Limited James T. McDeavitt, M.D., Chief Academic Officer, Carolinas HealthCare System Nicole Walker, Director, Abbott Ventures Inc.
| 4:45 pm - 5:00 pm | Networking Break | 5:00 pm - 6:00 pm | Emerging Company Showcase - BioPharma & Medtech Tracks BioPharma Clinipace Worldwide Oncotide Pharmaceuticals Aerial Biopharma, LLC Medtech Metabolon, Inc. MxBiodevices, LLC e-Nicotine Technology TransEnterix, Inc. GeneCentric Diagnostics, Inc.
| 6:00 pm - 7:30 pm | Networking Reception | 7:30 pm - 9:30 pm | Investor Dinner (By Invitation Only) Hosted by Hatteras Venture Partners, Intersouth Partners and Pappas Ventures | |
|
Thursday, February 28, 20137:30 am - 8:30 am | CEO Breakfast (Life Science CEO Only) N. Anthony (Tony) Coles, Jr., M.D., Chairman & CEO, Onyx Pharmaceuticals, Inc.
| 7:30 am - 8:30 am | Continental Breakfast | 8:30 am - 11:30 am | Partnering Meetings | 8:30 am - 9:45 am | Opening Remarks Samuel M. Taylor, President, North Carolina Biosciences Organization (NCBIO) David P. King, Chairman & CEO, LabCorp® The Honorable Pat McCrory, Governor of North Carolina
Keynote Speaker Ed Mathers, Partner, NEA Paul M. Black, President & CEO, Allscripts
| 9:45 am - 10:00 am | Networking Break | 10:00 am - 10:45 am | Emerging Company Showcase - BioPharma & Medtech Tracks BioPharma Liquidia Technologies Clearside Biomedical Clinverse, Inc. Medtech TearScience® Physcient, Inc. Advanced Animal Diagnostics
| 10:45 am - 11:00 am | Networking Break | 11:00 am - 11:45 am | New Models of Financing
Jon Civitarese, Director, Investment Banking, Leerink Swann LLC (Moderator)
Ben Auspitz, Partner, Fidelity BioSciences Thomas C. Hawes, M.D., Managing Director, Sandbox Industries; Managing Director, BlueCross BlueShield Venture Partners David Strong, President, Rex Health Ventures; COO, Systems Affiliations, UNC Health Care
Ronald Wooten, Managing General Partner, NovaQuest Capital Management, LLC
| 11:45 am - 1:30 pm | Closing Lunch
Presentation: A High-Throughput Optogenetic Toolkit for Screening of Medical Genetic Therapeutic Targets Morgan Howell and Param Sidhu, Students, North Carolina School of Science and Mathematics
Presentation of Life Science Leadership Award Robert A. Ingram, General Partner, Hatteras Venture Partners
Introduced by James B. Hunt, Jr., Governor of North Carolina (1977-1985; 1993-2001)
Featured Keynote Speaker Jack W. Szostak, Ph.D., Recipient of 2009 Nobel Prize for physiology or medicine; Investigator, Howard Hughes Medical Institute; and Professor of Genetics, Harvard Medical School
|
|
Print to Page
